Back close

847P The utility of serum amylase as a clinical marker in patients with multiple myeloma

Publication Type : Conference Proceedings

Publisher : Elsevier

Source : In ESMO 2021. https://doi.org/10.1016/j.annonc.2021.08.140

Url : https://www.sciencedirect.com/science/article/pii/S0923753421023541?via%3Dihub

Campus : Kochi

School : School of Medicine

Year : 2021

Abstract : Background Elevated amylase in Multiple myeloma (MM) was first described in 1988. It has been postulated that translocation of chromosome 1, where the amylase gene is situated is responsible for the ectopic production from the malignant plasma cells. Previous case reports have shown that patients with hyperamylasemia in MM are associated with extensive bone disease, rapid progression and shorter survival. The study was conducted to ascertain the degree of elevated amylase in MM patients.

Cite this Research Publication : C. Panthula, W.M. Jose, S. Krishnan. 847P The utility of serum amylase as a clinical marker in patients with multiple myeloma. In ESMO 2021. https://doi.org/10.1016/j.annonc.2021.08.140

Admissions Apply Now